Skip to main content
Clinical Trials/KCT0000014
KCT0000014Completed未知

Comparison of standard triple therapy and sequential therapy for Helicobacter pylori eradication in Korea

Daegu-Kyungpook Gastrointestinal Study Group0 sites348 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
348

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
18(Year) to 85(Year) (—)
Sex
All

Inclusion Criteria

  • 1) Ages between 18 and 85
  • 2) Peptic ulcer(active or inactive) in endoscopy and positive for rapid urease test
  • 3) No peptic ulcer in endoscopy but positive for rapid urease test, who want to eradicate the H.pylori
  • 4) Participants who agree to participate in this study after informed consent

Exclusion Criteria

  • 1) Patients who refused to participate in this study
  • 2) Paticipants with a history of treatment for H.pylori
  • 3) Use of proton pump inhibitor, antibiotics, H2-receptor antagonists, or bismuth in the previous 2 weeks
  • 4) Concomitant use of anticoagulants, aspirin or steroids
  • 5) History of gastric resection including endoscopic mucosal resection
  • 6) Combined severe cardiovascular, pulmonary or endocrine disorders
  • 7) Serious hepatic or renal dysfunction
  • 8) hematologic disorders
  • 9) Any kinds of malignant diseases
  • 10) pregnancy or lactation, women who were not willing to practice acceptable contraception

Investigators

Sponsor
Daegu-Kyungpook Gastrointestinal Study Group

Similar Trials